P

Pharming Group
PHARM

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€503.37M
EV
€449.69M
Shares Outstanding
683.93M
Beta
0.60

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€1.90
P/E 2025E
-
P/Revenue 2025E
1.74x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Pharming Group N.V.

gainify

P

Pharming Group N.V.

PHARM

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 este...

Sector

Healthcare

Industry

Biotechnology

CEO

de Vries, Sijmen

Employees

404

IPO Date

1999-06-16

Headquarters

Darwinweg 24, Leiden, Zuid-Holland, 2333 CR, Netherlands

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved